预加载
医学
后负荷
心室辅助装置
离心泵
心脏病学
人口
重症监护医学
心力衰竭
内科学
作者
Mark N. Belkin,Viktoriya Kagan,Colleen Labuhn,Sean P. Pinney,Jonathan Grinstein
标识
DOI:10.1016/j.cardfail.2021.11.016
摘要
Abstract
The HeartMate 3 left ventricular assist device (LVAD) is now the only centrifugal pump intended for durable support being actively manufactured and implanted for adults in the United States. The changes in preload and afterload that accompany common clinical scenarios experienced by patients with an LVAD will cause specific changes to the LVAD pump parameters, namely, the pump power, pulsatility index, and flow. Appropriate care of this unique, and growing, population requires a full understanding of these variables as well as the underlying physiologic principles governing their derivation. The aim of this review is to focus on the updated functionality of the HeartMate 3, specifically in comparison to the HeartMate II, as well as the application of pump parameter interpretation to common clinical scenarios.
科研通智能强力驱动
Strongly Powered by AbleSci AI